Fully Implantable Eye Blink Motor Neuroprosthesis for Facial Nerve Paralysis

Information

  • Research Project
  • 7054991
  • ApplicationId
    7054991
  • Core Project Number
    R43EY017247
  • Full Project Number
    1R43EY017247-01
  • Serial Number
    17247
  • FOA Number
  • Sub Project Id
  • Project Start Date
    7/15/2006 - 18 years ago
  • Project End Date
    6/30/2008 - 16 years ago
  • Program Officer Name
    WUJEK, JEROME R
  • Budget Start Date
    7/15/2006 - 18 years ago
  • Budget End Date
    6/30/2008 - 16 years ago
  • Fiscal Year
    2006
  • Support Year
    1
  • Suffix
  • Award Notice Date
    7/14/2006 - 18 years ago
Organizations

Fully Implantable Eye Blink Motor Neuroprosthesis for Facial Nerve Paralysis

[unreadable] DESCRIPTION (provided by applicant): The goal of this program is to create a totally implantable stimulator device that can restore eye blink in patients with unilateral facial nerve paralysis. The system will record EMG from the intact eye to detect normal blink and stimulate the muscle of the paralyzed eye to create a synchronous blink. The implant will consist of a thin, ceramic package placed subcutaneously near the mastoid with a small number of surface electrodes sutured to the muscles placed with minimally-invasive facial endoscopy. In Phase I, the feasibility of the approach will be demonstrated by acutely stimulating the eye muscles of patients with facial nerve paralysis using transcutaneous electrodes. This study will confirm previous animal work in the area for human subjects and identify proper electrode placement and stimulation for functional and cosmetically acceptable eye closure. In Phase II, a fully implantable system will be developed for use in limited clinical trials with human subjects. The market for these devices is relatively small with annual patient populations on the order of a few thousand per year. For patients with chronic facial paralysis, however, the restoration of functional eye blink will provide a profound improvement in quality of life, and a reduction in the likelihood and costs of complications such as eye damage, infections and vision loss. [unreadable] [unreadable]

IC Name
NATIONAL EYE INSTITUTE
  • Activity
    R43
  • Administering IC
    EY
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    99375
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    867
  • Ed Inst. Type
  • Funding ICs
    NEI:99375\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    RIPPLE, LLC
  • Organization Department
  • Organization DUNS
    145387341
  • Organization City
    SALT LAKE CITY
  • Organization State
    UT
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    841052443
  • Organization District
    UNITED STATES